Developing a dementia-specific preference-­based quality of life measure (AD-5D) in Australia: a valuation study protocol by Comans, T.A. et al.
This is a repository copy of Developing a dementia-specific preference-based quality of life
measure (AD-5D) in Australia: a valuation study protocol .
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/124629/
Version: Published Version
Article:
Comans, T.A., Nguyen, K.H., Mulhern, B. et al. (8 more authors) (2018) Developing a 
dementia-specific preference-based quality of life measure (AD-5D) in Australia: a 
valuation study protocol. BMJ Open, 8. e018996. ISSN 2044-6055 
https://doi.org/10.1136/bmjopen-2017-018996
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial (CC BY-NC) 
licence. This licence allows you to remix, tweak, and build upon this work non-commercially, and any new 
works must also acknowledge the authors and be non-commercial. You don’t have to license any derivative 
works on the same terms. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
 1Comans TA, et al. BMJ Open 2018;8:e018996. doi:10.1136/bmjopen-2017-018996
Open Access 
'HYHORSLQJDGHPHQWLDVSHFLÀFSUHIHUHQFH
EDVHGTXDOLW\RIOLIHPHDVXUH$''LQ
$XVWUDOLDDYDOXDWLRQVWXG\SURWRFRO
Tracy A Comans,1,2 Kim-Huong Nguyen,2,3 Brendan Mulhern,4 Megan Corlis,2,5 
Li Li,3 Alyssa Welch,1,2 Susan E Kurrle,2,6 Donna Rowen,7 Wendy Moyle,3 
Sanjeewa Kularatna,8 Julie Ratcliffe2,9
To cite: Comans TA, 
Nguyen K-H, Mulhern B, 
et al.  Developing a dementia-
speciic preference- based 
quality of life measure (AD-
5D) in Australia: a valuation 
study protocol. BMJ Open 
2018;8:e018996. doi:10.1136/
bmjopen-2017-018996
 Ź Prepublication history for 
this paper is available online. 
To view these iles, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2017- 
018996).
Received 4 August 2017
Revised 14 November 2017
Accepted 21 November 2017
For numbered afiliations see 
end of article.
Correspondence to
A/Prof Tracy A Comans;  
 t. comans@ uq. edu. au
Protocol
AbstrACt
Introduction Generic instruments for assessing health-
related quality of life may lack the sensitivity to detect 
changes in health speciic to certain conditions, such as 
dementia. The Quality of Life in Alzheimer’s Disease (QOL-
AD) is a widely used and well-validated condition-speciic 
instrument for assessing health-related quality of life for 
people living with dementia, but it does not enable the 
calculation of quality-adjusted life years, the basis of cost 
utility analysis. This study will generate a preference-
based scoring algorithm for a health state classiication 
system -the Alzheimer's Disease Five Dimensions (AD-5D) 
derived from the QOL-AD.
Methods and analysis Discrete choice experiments 
with duration (DCE
TTO
) and best–worst scaling health state 
valuation tasks will be administered to a representative 
sample of 2000 members of the Australian general 
population via an online survey and to 250 dementia 
dyads (250 people with dementia and their carers) via 
face-to-face interview. A multinomial (conditional) logistic 
framework will be used to analyse responses and produce 
the utility algorithm for the AD-5D.
Ethics and dissemination The algorithms developed will 
enable prospective and retrospective economic evaluation 
of any treatment or intervention targeting people with 
dementia where the QOL-AD has been administered and 
will be available online. Results will be disseminated 
through journals that publish health economics articles 
and through professional conferences. This study has 
ethical approval.
IntroduCtIon 
Economic evaluation has become widely 
used as a method for assessing the value for 
money of health intervention programmes in 
Australia and overseas.1 The most prevalent 
form of economic evaluation is cost utility anal-
ysis, which compares interventions in terms of 
their incremental cost per quality-adjusted life 
year (QALY). The QALY is a single measure of 
outcome that takes into account both quantity 
of life (survival) and health-related quality of 
life (morbidity). The measurement of QALYs 
relies on a single preference-based index 
measure of health: a utility weight.
There are a large number of health-related 
quality of life instruments available to derive 
utility weights. The most frequently used are 
generic instruments suitable for any health 
condition; however an increasing number 
of condition-specific instruments are avail-
able. All preference-based measures have two 
common elements: a health state classifica-
tion system that can be used to categorise all 
patients with the condition of interest and a 
means of obtaining a utility score for all states 
defined by the classification system.2
Previous studies assessing the health of 
people with dementia have used both generic 
(the 15-Dimensions,3–5 Assessment of Quality 
of Life,6–8 Quality of Well-being,9–11 Health 
Utilities Index,12–14 EuroQol-5-Dimensions 
(EQ-5D))15–17 and disease-specific (Dementia 
Quality of Life - Utility - (DEMQOL-U))2 18 19 
preference-based instruments. Generic instru-
ments are regularly recommended by health 
technology assessment organisations and 
regulatory authorities on the basis that they 
facilitate comparisons across different health 
conditions and diseases,20 thus addressing 
strengths and limitations of this study
 Ź Utility values will be able to be calculated for any 
treatment or intervention targeting people with 
dementia where the Quality of Life in Alzheimer’s 
disease has been administered.
 Ź Preference value sets from both general population 
and dementia dyads will be modelled and compared.
 Ź The study has a broad range of investigators with 
input in the design from consumers and aged care 
organisations.
 Ź The valuation methods used may not be readily 
understood by people with dementia, thereby 
limiting the ability to value quality of life from their 
own perspective.
 Ź The ability of the study to generate speciic 
algorithms for people with dementia and their carers 
will be impacted if recruitment targets are not met.
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the health system’s objective of allocative efficiency. 
However, generic instruments may lack the coverage 
to detect change in important aspects of certain condi-
tions. For example, the five dimensions of EQ-5D lack 
attributes to capture cognition21 and relationships with 
family and social support22 that are important domains 
in measuring the quality of life of people with dementia. 
Those limitations have motivated the recent development 
of the DEMQOL-U, a preference-based instrument gener-
ated from the DEMQOL, a dementia-specific quality of 
life instrument.23 However, the DEMQOL-U’s use for 
people with dementia may be limited because it does not 
directly measure physical health dimensions18 and is time 
consuming to complete.24
Our team has recently developed a new health state 
classification system, the alzheimer's disease five  dimen-
sions  (AD-5D)25 based on the QOL-AD nursing home 
version.26 The QOL-AD, originally developed for people 
with dementia living in the community,27 is the quality of 
life measure for people with dementia recommended in 
European guidelines due to its brevity, validity and wide 
usage.28 The AD-5D development process involved the 
use of statistical methods (psychometric, factor and Rasch 
analyses) to identify five key dimensions (‘memory’, 
‘mood’, ‘physical health’, ‘living situation’ and ‘do things 
for fun’) and subsequently select items to represent the 
dimensions and generate the health state classification 
system. These five items appear in both QOL-AD nursing 
home and community versions.
The purpose of this study is to generate a prefer-
ence-based scoring algorithm for the AD-5D, the health 
state classification system derived from the QOL-AD. This 
will be achieved by eliciting values for a selection of health 
states and conducting statistical modelling to develop an 
algorithm that derives utility values for all possible health 
states defined by the AD-5D descriptive system. This 
paper describes the process and methodology we will use 
to develop the utility values for the AD-5D (summarised 
in figure 1). When complete, this algorithm will enable 
data collected from any administration of the QOL-AD 
to be used in the economic evaluation of treatments and 
interventions for people diagnosed with dementia.
AIMs
This study has two main objectives:
 Ź To value health states from the AD-5D descriptive 
system with a representative sample of the general 
population and a sample of dementia dyads (a person 
with dementia and a primary carer) in Australia using 
discrete choice experiment with duration (DCE
TTO
) 
and best–worst scaling (BWS) elicitation techniques.
 Ź To identify any potential differences in the utility 
values elicited from the general population and those 
from the dementia dyads and between the two elicita-
tion methods of DCE and BWS.
MEthods And AnAlysIs
Preference elicitation methods
The most commonly used preference elicitation methods 
for valuing health states include standard gamble 
(SG),12 29 30 time trade-off (TTO),2 31 32 DCE33–35 and BWS 
(a particular form of DCE).36–38 Historically, researchers 
have favoured the SG and TTO to value health states.20 
Figure 1 Process and methodology of the AD-5D project. AD-5D, Alzheimer ' s Disease Five Dimensions; BWS, best–worst 
scaling; QOL-AD, Quality of Life in Alzheimer’s disease.
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However, these methods have been criticised on the 
grounds of task complexity,39 intensity of administra-
tion40 and potential contamination by risk attitudes and 
time preference.41 Consequently, methods such as DCE 
and BWS have gained significant popularity in health 
economics research because they use an ordinal ranking 
procedure, and therefore present a different cognitive 
challenge for respondents, avoiding the use of iterative 
procedures.42 43 They can also be administered in both 
face-to-face and online settings, while online survey meth-
odology for SG and TTO arguably requires further devel-
opment to guarantee reliable results.44 45
In this project, we will use DCE with survival duration 
(DCE
TTO
) and BWS to elicit preferences for health states 
described by the AD-5D. A DCE presents individuals with 
a number of hypothetical health states (ie, choice sets), 
each containing a number of alternatives with different 
attributes between which individuals are asked to choose. 
While this form of DCE can provide information on the 
relative preference of one health state over others, its 
derived values are not anchored on the 0–1 utility scale,46 
thus cannot be used directly for QALY calculation. The 
DCE
TTO
 method was developed to directly anchor rela-
tive preferences to the utility scale through the inclusion 
of a survival/duration attribute, while fitting within the 
constraints of random utility theory.46 In our DCE
TTO
, 
choice sets presenting levels of the five dimensions of the 
AD-5D (memory, mood, physical health, living situation 
and do things for fun) and one survival duration attri-
bute will be presented. Each dimension has four ordinal 
severity levels (‘excellent’, ‘good’, ‘fair’ and ‘poor’). A 
duration attribute with four levels (1, 4, 7 and 10 years) 
will be included to investigate individuals’ preferences 
with respect to survival durations.
BWS is a stated-preference method that presents 
respondents with a series of hypothetical health states 
and asks them to identify each state’s best and worst attri-
bute, hence offering the ability to compare attributes and 
associated levels within a single health state. Compared 
with a DCE
TTO
, BWS is less cognitively complex and may 
therefore be more appropriate for vulnerable groups 
such as older people or people with limited cognitive 
function.47–49 In this project, we will use a profile case 
BWS,50 in each of the tasks, respondents will be asked to 
pick the best and worst attribute of a health state.38
Experimental design and construction of choice sets
Discrete choice experiment tasks
The experimental design needs to determine both the 
total number of health states to be included in the valu-
ation study and the combinations of health states to be 
valued by each respondent. The combination of attri-
butes (five AD-5D dimensions and one duration) and 
levels (four levels for each attribute) results in the full 
factorial of 4096 possible health state profiles and over 
16 million possible pairwise combinations (4096×4095). 
For practical purposes, a subset of these will be selected 
from a candidate set to reduce the number of health 
states used in the experiment while maximising the effi-
ciency of the design.
A design maximised for the multinomial logit (MNL) 
model based on D-efficiency criteria will be used to 
generate 200 pairwise choice sets using the design soft-
ware NGene.51 We will generate a design that can esti-
mate the health state dimension and duration level main 
effects, as well as interactions between the health state 
dimensions and duration required to anchor DCE
TTO
 
data on the full health—dead scale. Previous research 
suggests that participants can efficiently handle 10 
choice sets at a time if they do not have any cognitive 
impairment,47 while five to six choice sets are optimal for 
people with mild cognitive impairment.52 Consequently, 
the full design will be divided into 20 blocks (versions) of 
the survey with 10 choice sets per block for the general 
population survey and 40 blocks with five choice sets per 
block for the dementia dyads interview. The blocking 
design will ensure balance among attribute levels.53 The 
construction of choice sets will also allow both the main 
effects (the effect of each attribute) and interaction 
effects between the attribute and duration to be deter-
mined. An example of a DCE
TTO
 choice task is shown in 
table 1.
Best–worst scaling task
In each BWS choice set, only one health state based on 
the AD-5D is included. An orthogonal array will generate 
health state profiles for use in the BWS to minimise multi-
collinearity among different levels of the attributes, thus 
optimising the design. A total of 16 health states will be 
generated. The full design is separated into four blocks so 
that each respondent will be presented with four choice 
sets for valuation. The blocks will be used for both the 
Table 1 Presentation of a DCE task
Health description 
A
Health description 
B
You have poor 
physical health
You have excellent 
physical health
You have good 
mood
You have fair mood
You have fair 
memory
You have fair memory
You have good living 
situation
You have fair living 
situation
You have good 
ability to do things 
for fun
You have good ability 
to do things for fun
You live in this state 
for 4 years and then 
you die.
You live in this state 
for 7 years and then 
you die.
Which scenario 
do you think is 
better?
ჳ ჱ
DCE, discrete choice experiment.
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general population survey and dementia dyad interviews. 
An example of a BWS choice task is shown in table 2.
survey format
Debate exists as to whose preferences are important 
when assessing healthcare.54 A prevailing view is that the 
general public funds services in a public health system and 
therefore their preferences should be taken into account 
when assessing programme for funding. On the contrary, 
other views are that only people who have experienced 
the condition could provide a reasonable perspective 
to inform preferences for that condition. Patient and 
public preferences can vary, with the public often framing 
aspects such as mobility and leisure constraints more 
negatively than people experiencing a condition where 
these aspects are impacted.55 In our project, the survey 
will be administered to both the general population 
and to dementia dyads so that either value is available to 
inform economic evaluations.
General public
A web-based survey that contains three modules will be 
administered to a sample of the Australian general popu-
lation in October to December 2017. In the first module, 
respondents will be given an introduction to the study 
and required to provide consent to continue the survey. 
Demographic data will be collected (eg, gender, age, 
education, marital status and employment) that can be 
used to determine the representativeness of the sample 
compared with the Australian population. In addition, 
respondents will be required to self-complete two quality 
of life questionnaires, the EQ-5D-5L and the QOL-AD 
(community living version) before commencing the main 
tasks.
The second and third modules will contain the DCE
TTO
 
tasks (10 choice sets) and the BWS tasks (four choice sets). 
The order of these modules will be randomly assigned to 
eliminate order effects bias in the responses: half of the 
general population sample will complete DCE
TTO
 first, 
the other half BWS first. At the start of each module, 
respondents will be given information and instructions 
on how to complete the DCE
TTO
 or BWS tasks and shown 
a sample task. To assess internal reliability and consis-
tency of responses, 1 repeated choice set (from each of 
the DCE
TTO
 or BWS blocks) and 1 dominant choice set 
will be included, creating 12 DCE and 6 BWS choice sets 
to be presented to each general population participant.
At the end of the DCE
TTO
 and BWS modules, respon-
dents will be asked to rate their difficulty completing each 
task. At the end of the survey, respondents will be asked 
to compare the difficulty levels between DCE
TTO
 and BWS 
tasks and provide information on their prior experience 
of dementia.
Dementia dyads (one person with dementia and a primary carer)
A survey with three modules will be administered to 
dementia dyads during a face-to-face interview. The first 
module will collect basic demographic data (eg, gender, 
age, education, marital status and employment), experi-
ence with dementia such as type of dementia, time since 
formal diagnosis and quality of life (using the EQ-5D-5L 
and the QOL-AD). The person with dementia will 
complete a General Practitioner-Cognition Test (GP-Cog) 
task as a quick reliable screen of cognitive function,56 
while the carer will be asked questions about their care 
experience, time commitment and her/his own health. 
The second and third modules consist of DCE
TTO
 and 
BWS tasks. To reduce the cognitive burden for people 
with dementia, fewer choice sets (five DCE
TTO
 choice sets 
and four BWS choice sets) will be administered during 
interviews.52 A standard script will be created as part of 
the interview protocol to explain the DCE
TTO
 and BWS 
tasks to dementia dyads in plain language, with standard 
prompts if required.
sample size and recruitment
Two different samples are required to achieve the study 
objectives: the general population and the dementia 
dyad. The current theory of sampling determines that 
sample sizes are based on the characteristics of the study 
design, such as the number of attributes, the size of the 
population and the statistical power that is required of 
the model derived. Based on the suggestions in the liter-
ature and previous studies using DCE
TTO
 and BWS meth-
odology,40 47 we have set our recruitment target at 2000 
members of the general population and 250 dementia 
dyads (250 people with dementia and 250 carers).
Quotas will be set for age, gender and geographic area 
during recruitment for the online survey to ensure the 
sample is representative of the Australian population. 
Survey respondents will be sourced from an existing 
Australian online panel, administered by PureProfile. 
This panel is drawn from volunteers (aged 18 and above 
and able to give consent) in the general population who 
are paid a small amount by the panel administrators for 
completion of the survey. The advantage of this approach 
is that a population can be drawn from the total available 
chosen based on prespecified criteria such as age and 
gender, thereby ensuring that a broadly representative 
population sample is obtained. Each respondent will use 
a web link to access the survey, so is able to self-complete 
at their convenience.
The recruitment process is guided by Australia’s National 
Health and Medical Research Council National State-
ment on Ethics Chapter 4.5.57 The statement articulates 
Table 2 Presentation of a BWS task
Best Health description Worst
O You have good memory O
O You have poor mood O
O You have excellent physical health O
O You have fair living situation O
O You have fair ability to do things for fun O
BWS, best–worst scaling.
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the right of people with a cognitive impairment to partici-
pate in research and outlines the considerations that need 
to be taken in this vulnerable population to ensure risks 
and burdens are justified. A sample of dementia dyads 
will be recruited from Queensland, New South Wales and 
South Australia from October 2017 to September 2018. A 
comprehensive recruitment approach will be undertaken 
by contacting eligible participants through aged care 
providers, residential aged care facilities and commu-
nity centres in both metropolitan and regional areas. 
Purposeful sampling will be used with quotas set (eg, resi-
dential and community dwelling, gender, age) to ensure 
the generalisability of the findings. Recruitment follows 
a two-step process. First, the primary caregiver is phoned 
by a member of the research team after registration. A 
brief screening using set questions written for the study is 
used to assess suitability for inclusion into the study. The 
process of participation is explained and the caregiver 
is asked whether this is something that the person with 
dementia (PWD) would be capable of and comfortable 
with. If during the telephone conversation it is clear that 
the PWD has severe dementia or is unable to respond to 
questions or is likely to be distressed by an interview from 
an unfamiliar person, the person is excluded from partic-
ipation. If preliminary eligibility is determined, a face-to-
face interview is booked and information about the study 
is posted to the participants.
Second, the research assistant checks on arrival for 
interview that the participant information sheet has been 
received and goes through this with the person and the 
carer, reminding them that participation is voluntary and 
they can withdraw or stop at any time. Consent to partici-
pate is then obtained (the PWD’s consent is witnessed by 
the primary caregiver). Interviewers will be people with 
experience in working with PWD and will have had addi-
tional training to be alert for signs of distress and modify 
or discontinue the interview as appropriate.
Pilot study
Pilot studies will be conducted with a subset of 200 (of 
2000) from the general population sample and 25 (of 
250) dementia dyads. The pilot aims to ascertain compre-
hension and understanding of the choice set tasks, attri-
butes and their levels as well as the functioning of the 
survey instrument. The pilot will highlight any procedural 
issues for the experimental design of the survey and allow 
revisions if required. The average time taken during the 
online survey pilot will be used to set a minimum time for 
respondents to complete the main survey. Data from the 
pilot will be analysed to confirm the face validity of the 
survey instrument.
A think-aloud technique will be used in the pilot 
interviews with the dementia dyads to gauge participant 
understanding of the tasks and provide insight into the 
factors underlying the preferences of participants.58 By 
using the ‘think-aloud’ approach during the pilot, we 
are asking respondents to explain their thought process 
for making choices. If they repeatedly indicate they do 
not understand, or if the interviewer (who has experi-
ence working with PWD) deems they do not understand, 
transcripts and recordings of the interviews will be used 
by the research team, combined with GP-Cog scores, to 
review the recruitment and interviewing process for the 
remaining dyads.
Analytical plan
We will use an MNL (conditional) framework as outlined 
by McFadden59 to analyse both DCE
TTO
 and BWS 
responses. For both DCE
TTO
 and BWS, random effect 
utility functions will be estimated following the Random 
Utility Theory’s argument that the utility value that an 
individual attaches to an attribute in a choice scenario 
can be summarised by an explainable (fixed) component 
and an unexplainable (random) component.
The specific utility function for the DCE
TTO
 responses 
will be modelled using the approach developed and 
described by Bansback et al46 due to its additional time 
duration attribute. The BWS-based utility values will be 
estimated using a two-stage approach. In stage 1, the 
coefficients of a random effect utility function will be 
estimated, from which the BWS values will be generated. 
These values will be anchored onto the 1–0 full health 
dead scale (required to generate QALYs) in stage 2 by 
mapping the modelled values from a small selection of 
health states used for AD-5D (ranging from mild to severe 
impairment) generated from the DCE
TTO
 study to the 
ordinal best–worst estimates to translate the best–worst 
estimates. While this represents a new technique in this 
field, the process is equivalent to mapping from BWS 
to utility values using TTO47 or mapping from DCE to 
TTO.42
EthICs And dIssEMInAtIon
A steering committee consisting of researchers, 
consumers and aged care industry representatives will 
coordinate the project and oversee any concerns arising 
from the conduct of the research. This committee will 
meet monthly for the duration of the project.
This project will develop utility value sets for a new 
dementia-specific economic analysis tool, the AD-5D. 
This will be the first dementia-specific preference-based 
measure with an Australian value set. Once developed, 
the AD-5D utility algorithms can be used to generate 
utility weights from any completion of the QOL-AD instru-
ment. The weights can be used to calculate QALYs for 
the economic evaluation of treatments and interventions 
targeting people with dementia. This algorithm is appli-
cable not only to current and future clinical trials and 
intervention studies but also for previously collected data 
using the QOL-AD, from which the AD-5D was derived.
Dissemination will occur through academic publica-
tions and conference presentations. Algorithms devel-
oped in the project will be available online. As well, the 
authors will record an online video demonstrating the 
use of the algorithms.
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